Stock screenerAll disclosures →
EDGAR →
MDGL
Conviction 61HealthcareScan · Mon, Aug 10, 2026Bullish engulfing
MDGL$516.14+1.20%
ResistanceSupportVol 14Insider sell11
Vol MA14 492.97K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price516.14
Change+1.20%
Gap-1.37%
Rel volume3.28×
Avg volume431.01K
Avg $ vol222.23M
SMA 20526.58
SMA 50514.91
SMA 200509.34
Price vs 50+0.24%
Price vs 200+1.33%
MA stackbullish
50/200 cross—
Supertrenddown · 558.69
RSI (14)49
MACD hist-2.56
MACD cross—
Stoch %K / %D58 / 55
ADX (14)20
+DI / −DI19 / 26
RSI divergence—
MACD divergence—
ATR %+4.60%
ADR %4.18%
52w high602.83
52w low345.73
From 52w high-14.38%
Above 52w low+49.29%
New 52w highNo
SqueezeOff
Bollinger width18.54%
%B0.39
Donchian pos58.01%
Donchian high566.18
Donchian low447.01
AVWAP (52w high)501.99
vs AVWAP high+2.82%
AVWAP (52w low)488.26
vs AVWAP low+5.71%
OBV trendFlat
Chaikin MF (20)0.25
Today vs 20d3.28×
Avg vol (14d)492.97K
Avg vol (20d)431.01K
Avg $ vol (20d)222.23M
Market cap11.92B
RS 3m (vs SPY)-10.34%
RS 6m (vs SPY)-4.05%
RS line new highNo
Trend template5/8
Technical rank44.9
1 week+7.08%
1 month-3.83%
3 months+1.20%
6 months+8.07%
1 year+50.79%
YTD-13.09%
P/E-41.37
P/B22.77
P/S12.44
P/FCF-62.76
EPS-12.85
Div yield—
ROE-55.05%
ROA-23.16%
Debt/Eq0.65
Current3.20
EV/EBITDA-40.10
Gross margin—
Net margin-30.08%
Rev growth432.05%
EPS growth38.12%
Price target687.15
Target upside33.13%
Analyst ratingBuy
Institutional109.77%
Ent. value11.97B
Revenue364.25M
Net income-57.94M
Gross profit—
Free cash flow-190.02M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out23.06M
Employees915
ListedTue, Feb 6, 2007
Free float16.43M
Float %71.6%
Short interest2.06M
Days to cover6.9d
Short volume43.4%
Squeeze score67 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.99 vs −$2.55
Last surprise+22.0% beat
Setup gradeB
Conviction61 / 100
Pattern quality—
Tech rank44.9 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MDGL
No recent disclosed trades by Congress in MDGL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MDGL · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Daly James M Director · Common Stock · 2026-06-17 | Grant | 454 | — | 2026-06-17 | 2026-06-18 |
Daly James M Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 766 | — | 2026-06-17 | 2026-06-18 |
BAKER BROS. ADVISORS LP Director · Common Stock · 2026-06-17 | Grant | 908 | — | 2026-06-17 | 2026-06-18 |
BAKER BROS. ADVISORS LP Director · Non-Qualified Stock Options (right to buy) · 2026-06-17 | Grant | 1.53K | — | 2026-06-17 | 2026-06-18 |
Brennan Daniel J. Director · Common Stock · 2026-06-17 | Grant | 404 | — | 2026-06-17 | 2026-06-18 |
Brennan Daniel J. Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 681 | — | 2026-06-17 | 2026-06-18 |
FOUSE JACQUALYN A Director · Common Stock · 2026-06-17 | Grant | 454 | — | 2026-06-17 | 2026-06-18 |
FOUSE JACQUALYN A Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 766 | — | 2026-06-17 | 2026-06-18 |
Levy Richard S Director · Common Stock · 2026-06-17 | Grant | 454 | — | 2026-06-17 | 2026-06-18 |
Levy Richard S Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 766 | — | 2026-06-17 | 2026-06-18 |
SEC filings
EDGAR filings in MDGL · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.